Welcome to the international HTA database
Showing [3431 Records] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2005 | Alberta Heritage Foundation for Medical Research (AHFMR) | Advance directives and health care costs and the end of life | |
| 2005 | Alberta Heritage Foundation for Medical Research (AHFMR) | Image-guided vacuum-assisted breast biopsy for suspicious, non-palpable breast lesions | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Triple therapy for COPD | |
| 2005 | Alberta Heritage Foundation for Medical Research (AHFMR) | Institutional medical incident reporting systems: a review | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Vaccines for metastatic hormone-refractory prostate cancer | |
| 2005 | Alberta Heritage Foundation for Medical Research (AHFMR) | Laparoscopic adjustable gastric banding for the treatment of clinically severe (morbid) obesity in adults: an update | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Cerebral protection devices for use during carotid artery stenting | |
| 2005 | Medical Advisory Secretariat (MAS) | Intrathecal baclofen pump for spasticity: an evidence-based analysis | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Circadian heart rate monitoring for psychiatric diagnosis | |
| 2005 | Alberta Heritage Foundation for Medical Research (AHFMR) | COX-2 inhibitors for dysmenorrhea | |
| 2005 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | [Introduction of advanced care to pre-hospital services in Quebec] | |
| 2005 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Vacuum-assisted wound closure therapy (V.A.C (R)) | |
| 2005 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Intraoperative neurophysiological monitoring during spinal surgery | |
| 2005 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Cerebral microdialysis as a tool for neuromonitoring following traumatic brain injury | |
| 2005 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | [The 13C-urea breath test for detection of helicobacter pylori: potential applications in Quebec ] | |
| 2005 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Botulinum toxin A for the treatment of refractory chronic anal fissures and internal anal sphincter achalasia in pediatric patients | |
| 2005 | WorkSafeBC | Alternative medicine: some definitions, evidence & references for health care benefits guidelines | |
| 2005 | WorkSafeBC | Artificial cervical and lumbar disc implants: a review of the literature | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Glycoprotein IIb/IIIa antagonists: a systematic review of randomized clinical trials in patients undergoing percutaneous coronary intervention | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of efficacy and safety evidence | |
| 2005 | Medical Advisory Secretariat (MAS) | Technologies for osteoarthritis of the knee: an evidence-based analysis | |
| 2005 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Botulinum toxin A for upper and lower limb spasticity: a systematic review | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Cinacalcet for secondary hyperparathyroidism | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Duloxetine for major depressive disorder and stress urinary incontinence | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Efficacy of external counterpulsation in the treatment of chronic angina | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Insulin glargine for type 2 diabetes | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Home-based chemotherapy for cancer: issues for patients, caregivers and the health care system | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Nitric oxide measurement system (NIOX) for monitoring response to asthma treatment | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Cryotherapy for prostate cancer | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Quantitative approaches to patient safety. Research in risk analysis and risk management as applied to radiotherapy | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Diabetic testing | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | A selected inventory of abstracts of Cochrane reviews on physiotherapy/physical therapy - interim report for expert advisory panel and the research team | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | EMDR for treatment of post-traumatic stress disorder | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Endometrial ablation for menorrhagia | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Interventional and intraoperative magnetic resonance imaging | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Insulin pen-fill formulations | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Profile of an HTA program: the AHFMR Health Technology Assessment Unit, 2002-2003 | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Patient lift technologies | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Prolotherapy for the treatment of chronic musculoskeletal pain | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Thalidomide for the treatment of multiple myeloma | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Advance directives for end-of-life care in the elderly - effectiveness of delivery modes | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Low level laser therapy for wound healing: an update | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Use of cannabis or cannabinoids for non-malignant chronic pain | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Living donor liver transplantation in children | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Botulinum toxin type A injection for achalasia and anal fissure | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Botulinum toxin type A injection into the ilopsoas muscle | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Adult to adult living donor liver transplantation | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Standard quality assessment criteria for evaluating primary research papers from a variety of fields | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Knowledge brokers: linking researchers and policy makers | |
| 2004 | Medical Advisory Secretariat (MAS) | Bispectral index monitor: an evidence-based analysis | |
| 2004 | Medical Advisory Secretariat (MAS) | Primary angioplasty for the treatment of acute ST-segment elevated myocardial infarction: an evidence-based analysis | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Evaluation of photodynamic therapy for the treatment of exudative age-related macular degeneration (ARMD) with subfoveal neovascularization | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Impact of radiation wait times on risk of local recurrence of breast cancer: early stage cancer with no chemotherapy | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ximelagatran in prevention of cardiovascular events | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Inteferon-based therapies for chronic Hepatitis C virus infection: an assessment of clinical outcomes | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Virtual colonoscopy | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Pneumatic compression therapy on venous insufficiency | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gefitinib for inoperable or recurrent non-small cell lung cancer | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Laronidase | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Water jet systems for surgical dissection and resection | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | A clinical and economic review of telephone triage services and survey of Canadian call centre programs | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | An economic analysis of drug eluting coronary stents: a Quebec perspective | |
| 2004 | WorkSafeBC | CRPS (Complex Regional Pain Syndrome): towards the development of diagnostic criteria and treatment guidelines | |
| 2004 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Use of carmustine implants (GLIADEL wafer) in patients with malignant glioma at The McGill University Health Centre | |
| 2004 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | The use of biventricular pacemakers at the McGill University Health Centre | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Comparison of lung volume reduction surgery with medical management for emphysema | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Bevacizumab for advanced colorectal cancer | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ciclesonide for asthma | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ranolazine for the treatment of stable angina | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ximelagatran for prevention and treatment of venous thromboembolism | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Submandibular gland transfer for preservation of salivary function | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Omalizumab as add-on therapy to inhaled steroids for asthma | |
| 2004 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | The gastric banding procedure: an evaluation | |
| 2004 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | The use of matrix coils in the treatment of cerebro-vascular aneurysms | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Auditory brain stem implants | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Insulin detemir for diabetes mellitus | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Surgical anesthesia delivered by non-physicians | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Implantable miniature telescope for treating age-related macular degeneration | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Low-intensity ultrasound (Exogen (TM)) for the treatment of fractures | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Postural-support devices | |
| 2004 | WorkSafeBC | Lateral epicondylitis | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Bisphosphonate agents for the management of pain secondary to bone metastases: a systematic review of effectiveness and safety | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Endoscope-based treatments for gastroesophageal reflux disease | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Infliximab (Remicade (R)) for the treatment of ankylosing spondylitis | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Etanercept for the treatment of ankylosing spondylitis | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Pimecrolimus (Elidel (R)) for atopic dermatitis | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Health care technology at home: issues in organization and delivery in Quebec | |
| 2004 | WorkSafeBC | Tinnitus retraining therapy | |
| 2004 | WorkSafeBC | Extracorporeal shock wave therapy for treating musculoskeletal conditions: first update | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Evidence for the benefits of telecardiology applications: a systematic review | |
| 2004 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Hospital technology at home: portable oxygen therapy in COPD | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | B-type natriuretic peptide for diagnosing congestive heart failure | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Gabapentin for non-malignant chronic pain | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Low density lipoprotein apheresis for the treatment of familial hypercholesterolemia | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Sclerotherapy for leg varicose veins | |
| 2004 | Alberta Heritage Foundation for Medical Research (AHFMR) | Systematic review of the social, ethical, and legal dimensions of genetic cancer risk assessment technologies | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gastroduodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions | |
| 2004 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gefitinib for advanced or metastatic non-small cell lung cancer |